100
Participants
Start Date
March 30, 2023
Primary Completion Date
April 30, 2024
Study Completion Date
April 30, 2024
Ondansetron
Administered Medication
Dexamethasone
Administered Medication
Beth Israel Deaconess Medical Center, Boston
Beth Israel Deaconess Medical Center
OTHER